Prelude Therapeutics
PRLD
#9265
Rank
โ‚น4.46 B
Marketcap
โ‚น81.12
Share price
-0.65%
Change (1 day)
-69.87%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -โ‚น179.02

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น183.18. In 2022 the company made an earnings per share (EPS) of -โ‚น205.97 a decrease over its 2021 EPS that were of -โ‚น204.28.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น179.02-13.09%
2022-โ‚น205.970.83%
2021-โ‚น204.28-61.3%
2020-โ‚น527.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น184.02 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA